Quantcast

Latest Pharmaceuticals policy Stories

2014-05-06 23:02:36

Report: Bill Could Increase Health Costs by $6 Billion Washington D.C. (PRWEB) May 06, 2014 Legislation to exempt drugstores from certain safety and performance standards (S.3995-B and A.5723-B) raises patient safety concerns and, according to a new study, could increase prescription drug costs by $392 million in 2015 and $6 billion over the next decade. The study was conducted by the health research firm Visante for the Pharmaceutical Care Management Association (PCMA). The legislation...

2014-05-06 15:09:07

Hispanic seniors are 35 percent less likely to have prescription drug coverage despite the existence of the Medicare Prescription Drug Plan – also known as Part D – and the availability of assistance to help pay insurance premiums. That is the finding of a study released today in the journal Health Affairs. "These results indicate that disparities in prescription drug coverage exist between Hispanic and white Medicare beneficiaries, despite the existence of a potentially universal...

2014-05-06 12:26:53

Georgia Prevention Initiative Awareness Campaign ATLANTA, May 6, 2014 /PRNewswire-USNewswire/ -- According to the Centers for Disease Control and Prevention (CDC) in 2012, "Overdose deaths involving prescription opioid analgesics, which are medications used to treat pain, have increased to almost 17,000 deaths a year in the United States." That is the equivalent of a large jumbo jet full of people disappearing every week for one year! The Georgia Prescription Drug Abuse Prevention...

2014-05-06 08:33:54

DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c3n2v6/otc) has announced the addition of the "OTC Pharmaceuticals Market in Latin America 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The analysts forecast the OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing...

2014-05-06 08:33:35

NASHVILLE, Tenn., May 6, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and China's Gloria Pharmaceuticals Co. (SHE: 002437) announced today a joint research & development initiative. Each company has made a $1 million investment in Cumberland Emerging Technologies ("CET"), which is majority owned by Cumberland and partners with academic research centers to develop promising biopharmaceutical technologies. The new funds will be used to accelerate development...

2014-05-05 12:28:53

DALLAS, May 5, 2014 /PRNewswire/ -- According to new market research report the "Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018", published by MarketsandMarkets, The global Animal Antimicrobials and Antibiotics Market is valued at $3,340.8 Million in 2013 and is estimated to reach...

2014-05-05 08:28:20

SAN DIEGO, May 5, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will provide a corporate update and report first quarter 2014 financial results after the NASDAQ Global Select Market closes on Monday, May 12, 2014. That same day, Arena will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international...

2014-05-02 00:21:43

Company Remains Committed to Bringing Moxduo® to Market SYDNEY and BEDMINSTER, N.J., May 1, 2014 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Dr. John Holaday has stepped down as Managing Director and Chief Executive Officer. The Company's Board of Directors has appointed Dr. Edward Rudnic to Chief Executive Officer with immediate effect. Dr. Rudnic has been QRxPharma's Chief Operating Officer since early 2012. "This change in leadership was...

2014-05-01 23:07:07

The U.S. Pharmacopeial Convention (USP) has proposed new and revised standards for organic impurities in drug substances and drug products—one of the critical quality attributes that has the potential to affect drug safety and efficacy. Rockville, MD (PRWEB) May 01, 2014 The U.S. Pharmacopeial Convention (USP) has proposed new and revised standards for organic impurities in drug substances and drug products—one of the critical quality attributes that has the potential to affect drug...

2014-05-01 20:24:02

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dfhjv9/global_orphan) have announced the addition of the "Global Orphan Drugs Market 2014-2018" [http://www.researchandmarkets.com/research/dfhjv9/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018....


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related